Page 6 - Test PDF v5

« Back to Contents OVARIAN CANCER

LiFE re

Literature for ENYGO

Surgical treatment of primary ovarian fallopian tube and peritoneal cancer

Relevant articles retrieved Nov 2015 - Feb 2016

No Title Authors Journal Link to abstract
Gynecol Oncol.
1 The impact of debulking surgery in patients with node-positive epithelial Pereira et al. http://www.ncbi.nlm.nih.gov/
Int J Gynecol Cancer. pubmed/26979641
ovarian cancer: Analysis of prognostic factors related to overall survival and Ann Surg Oncol.
http://www.ncbi.nlm.nih.gov/
progression-free survival after an extended long-term follow-up period. pubmed/26509849
http://www.ncbi.nlm.nih.gov/
2 Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Mueller et al. pubmed/26832880
Ovary.

3 Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and Gasimli et al.
FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking
Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer
Network.

4 Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based Dehal et al. J Gastrointest Oncol. http://www.ncbi.nlm.nih.gov/
review-past, present and future. Eur J Surg Oncol pubmed/26941992
Eur J Surg Oncol.
5 Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surge- Huo et al. http://www.ncbi.nlm.nih.gov/
ry (CRS) in ovarian cancer: A systematic review and meta-analysis. pubmed/26453145

6 Peritonectomy procedures and HIPEC in the treatment of peritoneal carcino- Muñoz-Casares et al. http://www.ncbi.nlm.nih.gov/
matosis from ovarian cancer: Long-term outcomes and perspectives from a pubmed/26673283
high-volume center.

7 Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is Boisen et al. J Gastrointest Oncol. http://www.ncbi.nlm.nih.gov/
there a role? J Gastrointest Oncol pubmed/26941980

8 Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based Dehal et al. http://www.ncbi.nlm.nih.gov/
review-past, present and future. pubmed/26941992

9 Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Harter et al. http://www.ncbi.nlm.nih.gov/
Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperito- pubmed/26941446
neal Chemotherapy (HIPEC) in Ovarian Cancer.

10 Interval debulking surgery for advanced epithelial ovarian cancer. Tangjitgamol et al. Cochrane Database Syst Rev. http://www.ncbi.nlm.nih.gov/
Lancet. pubmed/26747297
11 Primary chemotherapy versus primary surgery for ovarian cancer. Gasparri et al. Lancet.
Gynecol Oncol. http://www.ncbi.nlm.nih.gov/
12 Author’s reply. Kehoe et al. pubmed/26638961

13 Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy Soleymani Majd et al. http://www.ncbi.nlm.nih.gov/
during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with Bogani et al. pubmed/26638963
stage IIIC-IV ovarian cancer: A surgical-histological analysis. Ataseven et al.
http://www.ncbi.nlm.nih.gov/
14 Surgical Techniques for Diaphragmatic Resection During Cytoreduction pubmed/26691220
in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and
Meta-analysis. Int J Gynecol Cancer. http://www.ncbi.nlm.nih.gov/
pubmed/26588238
15 Prognostic impact of debulking surgery and residual tumor in patients with
epithelial ovarian cancer FIGO stage IV. Gynecol Oncol. http://www.ncbi.nlm.nih.gov/
pubmed/26691222

International Journal of Gynecological Cancer, Volume 26, Supplement #1 Page 6